pharmaphorum

DECEMBER 9, 2020

COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. CREATION.co’s Lara Meyer explores why HCPs need more support. The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. A key concern that has emerged from the crisis is how COVID-19 will affect other areas of healthcare, particularly cancer diagnosis and treatment.

Hospitals 122

Hospitals Clinic Management Pharmaceutical Companies Pharmaceutical Companies 122

Outsourcing Pharma

DECEMBER 8, 2020

An expert from the clinical research technology specialist discusses how trial teams can use real-world evidence to improve study inclusivity.

119

119

Druggist

DECEMBER 9, 2020

Several factors can cause skin itchiness (also known as pruritus). Skin itch is commonly associated with eczema (dermatitis), psoriasis, chickenpox, insect bites, hives and other conditions. Several effective creams to stop itching can be purchased from supermarkets, pharmacies and online. Sale of some anti-itch creams is restricted to pharmacies only.

Compounding 97

Compounding People Management 97

Pharma Marketing Network

DECEMBER 7, 2020

Tune in now to listen to Darshan Talks Podcast, What a Clinical Trial Transparency Program Is (and Why You Need One). The post What a Clinical Trial Transparency Program Is (and Why You Need One) appeared first on Pharma Marketing Network.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

DECEMBER 8, 2020

Novartis has signed a multi-year agreement with RetinAI Medical, which will see the companies work together to use artificial intelligence (AI) tools to support ophthalmology and digital health projects. Both companies have already worked on pilot projects in this area. The first project under a new master agreement will involve a multi-centre international clinical study involving patients with neovascular age-related macular degeneration (nAMD).

122

122

Outsourcing Pharma

DECEMBER 10, 2020

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for womenâs cancers.

79

79

indispensable health

DECEMBER 8, 2020

What are good Characteristics of a pharmacy partner for an Ambulatory Surgery Center? When considering what characteristics an Ambulatory Surgery Center (ASC) should consider in a pharmacy partner “flexibility” is the first that comes to mind. Ambulatory Surgery Centers require a pharmacy partner that can be flexible to their unique situations. Every ASC has various needs and pharmacy providers must be able to provide custom services tailored to fit the outpatient surgery center’s needs.

Pharmacy Service Companies 52

Pharmacy Service Companies Controlled Substances Customer Service Documentation 52

pharmaphorum

DECEMBER 10, 2020

The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed. In a terse statement, the EU regulator confirmed its security had been breached and said it had launched an investigation with law enforcement, but would not be providing any additional information while that probe was underway.

Vaccines 111

Vaccines Documentation 111

Outsourcing Pharma

DECEMBER 7, 2020

A leader from data-centric CRO Quanticate shares perspective on how the pandemic has disrupted trials, and what tools and technologies can keep work going.

72

72

Pharma Mirror

DECEMBER 9, 2020

Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe from the potential hazardous effects for CO2 exposure from the dry ice that is keeping the COVID-19 vaccines cold. A national pharmacy chain contacted CO2Meter on December 1st asking about devices to detect the release of CO2 when dry ice sublimates.

Vaccines 52

Vaccines 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

DECEMBER 7, 2020

Tune in now to listen to Darshan Talks Podcast, Is Off-Label Marketing by a Pharma Company a Bad Thing? The post Is Off-Label Marketing by a Pharma Company a Bad Thing? appeared first on Pharma Marketing Network.

Labelling 49

Labelling 49

pharmaphorum

DECEMBER 9, 2020

Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go.

Vaccines 111

Vaccines FDA Adverse Reactions Documentation 111

Outsourcing Pharma

DECEMBER 10, 2020

The companyâs cancer drug, devimistat, has received orphan status from the agency for treating clear-cell sarcoma, pancreatic cancer, and other diseases.

FDA 69

FDA 69

Med Ed 101

DECEMBER 9, 2020

As a geriatric pharmacist, I can’t tell you the number of times I have seen amlodipine prescribed with the subsequent addition (usually a few weeks later) of furosemide. It is finally nice to have some solid evidence to back up what I have anecdotally seen in practice. A recent study looked at over 40,000 patients […]. The post Amlodipine Then Furosemide Prescribing Cascade appeared first on Med Ed 101.

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Marketing Network

DECEMBER 9, 2020

REGISTER NOW! The post Biotech Showcase | January 11-15, 2021 | Digital Event appeared first on Pharma Marketing Network.

52

52

pharmaphorum

DECEMBER 11, 2020

Embedding diversity into clinical research does not start and end at trial recruitment – the community needs processes and institutions that reflect society and provide representation. Greater representation among study designers, research teams, and funding committees would lead to greater diversity among research participants and help to tackle health inequalities.

Vaccines 99

Vaccines 99

Outsourcing Pharma

DECEMBER 10, 2020

Through organizations like the Association of Clinical Research Organizations, clinical research professionals are helping decentralized research evolve.

67

67

Pharma Times

DECEMBER 9, 2020

ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma

58

58

Pharma Marketing Network

DECEMBER 9, 2020

An extensive report by eMarketer, AI In Drug Discovery and Development , discusses how AI can speed up the drug discovery and development process while eliminating costs, how startups are taking first steps at utilizing AI’s power to streamline the process of bringing a drug to market, and current barriers preventing AI from its full potential in the drug making process.

59

59

pharmaphorum

DECEMBER 10, 2020

UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5 million (around $37 million) through a 90 pence per share placing.

95

95

Outsourcing Pharma

DECEMBER 7, 2020

The online DNA network has delved into self-reported data of more than 563,000 US adults to help identify genetic risk of infection and severe outcomes.

61

61

Pharma Times

DECEMBER 9, 2020

Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards

Communication 57

Communication 57

Med Ed 101

DECEMBER 6, 2020

I had a clinical post geared up today, but this was too important to pass up. It has come to my attention that there is not a pharmacist on Joe Biden’s COVID Advisory Board. A fellow colleague shared this information with me which was highly disappointing. Is this insane, or is it just me? We […]. The post If You Don’t Say Something, No One Will: Advocating For Pharmacy appeared first on Med Ed 101.

40

40

pharmaphorum

DECEMBER 8, 2020

Amanda Barrell speaks to Alfred Samuels on his experience of prostate cancer and diversifying clinical trials to include the Black, Asian and minority ethnic (BAME) community. Alfred Samuels’ stage 4 metastatic prostate cancer brought his 30-year career, which had seen him travel the world with the likes of Beyoncé, Oasis, and Bob Dylan, to a shuddering halt.

Medication Sorting 94

Medication Sorting Pharmaceutical Companies Pharmaceutical Companies 94

Outsourcing Pharma

DECEMBER 7, 2020

OSP's free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.

52

52

Pharma Times

DECEMBER 9, 2020

Agreement will utilise RetinAI's IT solutions and artificial intelligence tools to support projects in ophthalmology

52

52

pharmaphorum

DECEMBER 9, 2020

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is now breathing down its neck. The FDA has started its review of Nucala (mepolizumab) for the inflammatory condition, which results in the growth of nasal polyps in the nose that can obstruct airflow and cause mucus discharge, sometimes requiring surgical intervention.

FDA 90

FDA 90

pharmaphorum

DECEMBER 10, 2020

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions. Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine.

Vaccines 88

Vaccines Documentation FDA 88

pharmaphorum

DECEMBER 7, 2020

Tuesday has been dubbed “V-day” in the UK, when the first doses of Pfizer/BioNTech’s coronavirus vaccine will be distributed to the public outside of a clinical trial. Health secretary Matt Hancock reportedly came up with the wartime analogy to describe what will be the largest scale vaccination programme in the country’s history. The UK last week became the first country in the world to officially authorise the vaccine, which has so far shown an effectiveness of around 95% and minimal side effe

Vaccines 78

Vaccines 78

pharmaphorum

DECEMBER 8, 2020

A new Health Union survey reveals that people with chronic conditions feel that telehealth, despite its convenience and increased use throughout the COVID-19 pandemic, is generally less preferable than in-person visits, but can still serve as an occasionally suitable alternative. The survey is the fifth in Health Union’s ongoing COVID-19 Consumer Attitudes and Health Behaviors Survey series that captures “snapshots in time” that track the perspectives and health behaviors of people with chronic

76

76

pharmaphorum

DECEMBER 10, 2020

Shares in Rocket Pharmaceuticals have been living up to their name, shooting up following encouraging early-stage clinical trial results from a gene therapy for a serious inherited rare heart disease. Results came from a phase 1 trial of RP-A501 for treatment of Danon Disease and sent shares up 75% on the Nasdaq to more than $56, a five-year high. The surging stock price indicates the market’s confidence in gene therapy products after the successful launch of products such as Roche/Spark T

Immunization 60

Immunization 60

pharmaphorum

DECEMBER 11, 2020

ERT, a clinical services firm with expertise in digital technology is to merge with clinical imaging firm Bioclinica. The companies said that the combination will strengthen their offering to pharmaceutical and biotech companies. The transaction will integrate Bioclinica’s expertise in imaging with ERT’s expertise in electronic clinical outcome assessment, cardiac safety, respiratory and wearables.

Vaccines 60

Vaccines 60

pharmaphorum

DECEMBER 10, 2020

Boehringer Ingelheim has expanded its oncology focus for the second time this week by buying Swiss biotech NBE-Therapeutics, adding an antibody-drug conjugate (ADC) platform led by a drug for a hard-to-treat form of breast cancer. The German pharma group is paying €1.18 billion ($1.43bn) for all the shares in privately-held NBE, based in Basel, and says the biotech will remain at its current location and operate as a new site within its R&D network.

Vaccines 59

Vaccines Immunization FDA 59

pharmaphorum

DECEMBER 9, 2020

Addenbrooke’s Hospital in Cambridge will be the first in the world to use an artificial intelligence tool developed by Microsoft that promises to cut the time it takes to analyse computed tomography (CT) scans, and allow treatment to start sooner. The Project InnerEye tool was developed just down the road from Addenbrooke’s at Microsoft’s Cambridge research labs, and uses AI to highlight tumours and healthy tissue on patient scans, guiding an individual treatment plan.

Hospitals 59

Hospitals 59